JP2017533915A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533915A5
JP2017533915A5 JP2017523330A JP2017523330A JP2017533915A5 JP 2017533915 A5 JP2017533915 A5 JP 2017533915A5 JP 2017523330 A JP2017523330 A JP 2017523330A JP 2017523330 A JP2017523330 A JP 2017523330A JP 2017533915 A5 JP2017533915 A5 JP 2017533915A5
Authority
JP
Japan
Prior art keywords
ibs
patients
hmo
bacterial overgrowth
mucosal barrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523330A
Other languages
English (en)
Japanese (ja)
Other versions
JP7182872B2 (ja
JP2017533915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2015/050332 external-priority patent/WO2016066175A1/en
Publication of JP2017533915A publication Critical patent/JP2017533915A/ja
Publication of JP2017533915A5 publication Critical patent/JP2017533915A5/ja
Priority to JP2021103785A priority Critical patent/JP7301093B2/ja
Application granted granted Critical
Publication of JP7182872B2 publication Critical patent/JP7182872B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523330A 2014-10-29 2015-10-29 過敏性腸症候群の治療のための合成組成物および方法 Expired - Fee Related JP7182872B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021103785A JP7301093B2 (ja) 2014-10-29 2021-06-23 過敏性腸症候群の治療のための合成組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201470663 2014-10-29
DKPA201470663 2014-10-29
PCT/DK2015/050332 WO2016066175A1 (en) 2014-10-29 2015-10-29 Synthetic composition and method for treating irritable bowel syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021103785A Division JP7301093B2 (ja) 2014-10-29 2021-06-23 過敏性腸症候群の治療のための合成組成物および方法

Publications (3)

Publication Number Publication Date
JP2017533915A JP2017533915A (ja) 2017-11-16
JP2017533915A5 true JP2017533915A5 (cg-RX-API-DMAC7.html) 2018-11-08
JP7182872B2 JP7182872B2 (ja) 2022-12-05

Family

ID=55856643

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017523330A Expired - Fee Related JP7182872B2 (ja) 2014-10-29 2015-10-29 過敏性腸症候群の治療のための合成組成物および方法
JP2021103785A Active JP7301093B2 (ja) 2014-10-29 2021-06-23 過敏性腸症候群の治療のための合成組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021103785A Active JP7301093B2 (ja) 2014-10-29 2021-06-23 過敏性腸症候群の治療のための合成組成物および方法

Country Status (5)

Country Link
US (3) US20160346303A1 (cg-RX-API-DMAC7.html)
EP (1) EP3212197A4 (cg-RX-API-DMAC7.html)
JP (2) JP7182872B2 (cg-RX-API-DMAC7.html)
CN (2) CN115364113A (cg-RX-API-DMAC7.html)
WO (1) WO2016066175A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107108677B (zh) * 2014-10-24 2020-08-07 格礼卡姆股份公司 Hmo的混合物
US20160346303A1 (en) 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
PT3264922T (pt) * 2015-03-05 2025-01-07 Nestle Sa Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
ES2886951T3 (es) 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
WO2017071715A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
US10780103B2 (en) 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10857168B2 (en) 2016-02-24 2020-12-08 Glycom A/S Synthetic composition for microbiota modulation
ES2938355T3 (es) * 2016-05-05 2023-04-10 Glycom As Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
WO2017190755A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
MX2018015187A (es) * 2016-08-04 2019-04-24 Nestec Sa Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
KR102593408B1 (ko) * 2016-09-19 2023-10-25 프롤랙타 바이오사이언스, 인코포레이티드 정제된 인간 모유 올리고당 조성물
AU2016101768B4 (en) * 2016-09-28 2017-02-02 Grech, Brian James DR Treatment for Irritable Bowel Syndrome
GB201617519D0 (en) * 2016-10-14 2016-11-30 Genetic Analysis As A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
CN106668034A (zh) * 2017-01-13 2017-05-17 华中科技大学同济医学院附属协和医院 L‑岩藻糖在治疗消化道病变的药品和保健品中应用
EP3589139A4 (en) * 2017-03-01 2020-12-23 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
WO2019087140A1 (en) * 2017-11-02 2019-05-09 Glycom A/S One or more hmos for reducing or preventing fatigue and/or improving focus or concentration
US11452736B2 (en) 2017-11-30 2022-09-27 Glycom A/S Mixture of HMOs for treating wheat sensitivity
US11602545B2 (en) * 2017-12-05 2023-03-14 Glycom A/S Human milk oligosaccharides for treating migraine
BR112020011242A2 (pt) * 2017-12-08 2020-11-17 Jennewein Biotechnologie Gmbh mistura seca por pulverização de oligossacarídeos de leite humano
EP3743078A4 (en) * 2017-12-22 2022-01-19 Glycom A/S COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION
MX2020007197A (es) 2017-12-22 2020-09-03 Nestle Sa Composiciones para usar en la reduccion de la nocicepcion en infantes y niños pequeños.
US11642359B2 (en) 2018-07-12 2023-05-09 N.V. Nutricia Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment
JP2022513524A (ja) * 2018-12-19 2022-02-08 グリコム・アクティーゼルスカブ 低fodmap食を使用してヒトを治療するための組成物および方法
US20220054515A1 (en) * 2018-12-21 2022-02-24 Glycom A/S Composition and method for promoting intestinal barrier healing
US20220249526A1 (en) * 2019-06-12 2022-08-11 Glycom A/S Human milk oligosaccharides and compositions thereof for use in preventing, managing or treating symptoms related to migraine
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
WO2021094993A1 (en) * 2019-11-14 2021-05-20 Glycom A/S Synthetic composition for balancing the bile acid profile in the intestine
CN114761023A (zh) * 2019-11-27 2022-07-15 格礼卡姆股份公司 Hmo混合物
IT201900023016A1 (it) * 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
BR112022008956A2 (pt) 2019-12-06 2022-08-02 Nestle Sa Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
EP4076474A4 (en) * 2019-12-06 2024-02-28 Glycom A/S COMPOSITION CONTAINING 2'-FL AND DFL FOR USE IN A PAIN RELIEF METHOD
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物
WO2022118269A1 (en) * 2020-12-04 2022-06-09 Glycom A/S Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
US20240041949A1 (en) * 2020-12-09 2024-02-08 Meiji Co., Ltd. Composition comprising bacterium of the genus acidipropionibacterium or processed product thereof
WO2022155126A1 (en) * 2021-01-12 2022-07-21 Intrinsic Medicine, Inc. Methods and compositions for supporting human health during space travel
US11712445B2 (en) 2021-04-30 2023-08-01 Sourabh Kharait Compositions and methods for improving gastrointestinal function in subjects with renal disease
US20260165955A1 (en) * 2022-03-18 2026-06-18 Meiji Co., Ltd. Composition for controlling growth of bacteria of the genus collinsella and use thereof
JPWO2024019141A1 (cg-RX-API-DMAC7.html) * 2022-07-21 2024-01-25
WO2025196272A1 (en) * 2024-03-22 2025-09-25 Dsm Ip Assets B.V. Combination of mixtures of hmos with mfgm and their use
CN120570904A (zh) * 2025-07-14 2025-09-02 苏州一兮生物技术有限公司 一种用于预防和/或治疗腹泻的组合物及其用途

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663321A (en) 1984-06-26 1987-05-05 Merck & Co., Inc. Triazolobenzodiazepines and pharmaceutical use
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
WO2004026257A2 (en) 2002-09-20 2004-04-01 The Board Of Regents Of The University Of Texas System Treatment of irritable bowel syndrome and related bowel diseases
GB0312365D0 (en) 2003-05-30 2003-07-02 Univ Aston Novel 3-substituted-1, 4-benzodiazepines
WO2006035954A1 (en) * 2004-09-28 2006-04-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril compound
PL1991690T3 (pl) 2006-03-09 2014-07-31 Centre Nat Rech Scient Sposób wytwarzania sialilowanych oligosacharydów
US20110104282A1 (en) 2008-04-25 2011-05-05 Karolinska Institutet Innovations Ab New Therapy of Treatment of the Irritable Bowel Syndrome
EP2417144B1 (en) 2009-04-07 2017-08-23 Glycom A/S Synthesis of 2'-o-fucosyllactose
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
US8993740B2 (en) 2010-02-19 2015-03-31 Glycom A/S Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine
BR112012020791A2 (pt) 2010-02-19 2016-05-03 Glycom As produção de 6'-o-sialillactose e intermediários
US9119869B2 (en) * 2010-04-29 2015-09-01 Ronald J. Shebuski Mucin derived polypeptides
US9200091B2 (en) * 2010-07-12 2015-12-01 The Regents Of The University Of California Bovine milk oligosaccharides
KR20140001198A (ko) 2010-07-16 2014-01-06 글리콤 에이/에스 신규 시알로올리고당 유도체들의 합성
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
MX356184B (es) * 2010-12-31 2018-05-17 Abbott Lab Fórmulación pediátrica sintética que comprende un probiótico.
NZ611807A (en) * 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013016929A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
BR112013019522A2 (pt) * 2011-02-04 2019-09-24 Univ California dissialil lacto-n-tetraose (dslnt) ou as variantes, os isômeros, os análogos e os derivados da mesma para prevenir ou inibir doença do intestino
US20140057868A1 (en) 2011-02-21 2014-02-27 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
BR112013029203A2 (pt) 2011-05-13 2016-08-09 Glycom As método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano
EP2712362A4 (en) 2011-05-13 2014-12-24 Glycom As MANUFACTURE OF LACTO-N-TETRAOSE
BR112013029208A2 (pt) 2011-05-13 2017-02-14 Glycom As método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto
US20140235850A1 (en) 2011-09-30 2014-08-21 Glycom A/S Synthesis of hmo core structures
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
CN110301646A (zh) * 2012-03-27 2019-10-08 雅培制药有限公司 用于使用人乳寡糖调节细胞介导的免疫的方法
MX2014012362A (es) * 2012-04-13 2015-05-07 Trustees Boston College Composición prebiótica y métodos de uso.
JPWO2013161693A1 (ja) * 2012-04-27 2015-12-24 トライエックス・バイオメディカル株式会社 腸内細菌異常増殖による過敏性腸症候群の診断剤及び診断法
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
HK1231398A1 (zh) * 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20160346303A1 (en) 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
ES2886951T3 (es) 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
TWI715424B (zh) * 2020-01-22 2021-01-01 長春石油化學股份有限公司 電解銅箔、電極及包含其之鋰離子電池

Similar Documents

Publication Publication Date Title
RU2008140167A (ru) Применение неусвояемых сахаридов для лучшей адаптации младенцев после рождения
Ojetti et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial
Yasmin et al. Prebiotics, gut microbiota and metabolic risks: Unveiling the relationship
JP2021152062A (ja) 過敏性腸症候群の治療のための合成組成物および方法
RU2013128570A (ru) Олигосахаридная композиция для лечения острых инфекций дыхательных путей
JP2015523321A5 (cg-RX-API-DMAC7.html)
RU2008119992A (ru) Предупреждение заболеваний у детей, рожденных посредством кесарева сечения
RU2018107583A (ru) Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
JP2021504420A5 (cg-RX-API-DMAC7.html)
RU2006144870A (ru) Синергизм галактоолигосахаридов и полифруктозы
RU2005121665A (ru) Пребиотические композиции
JP2009535419A5 (cg-RX-API-DMAC7.html)
MX337667B (es) Combinacion simbiotica para mejorar la microbiota intestinal.
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
RU2013128594A (ru) Композиция для применения с целью предупреждения и/или лечения состояний кожи и заболеваний кожи
RU2017113997A (ru) Система детской смеси с адаптивными концентрациями олигосахаридов грудного молока (огм)
CN101801220A (zh) 含有非活的双歧杆菌和非消化性寡糖的营养物
CN105283195A (zh) 用于治疗过敏患者的感染的合生素组合物
JP2019508486A5 (cg-RX-API-DMAC7.html)
Licht et al. Prebiotics for prevention of gut infections
CN101686995A (zh) Hiv患者肠内菌群的调节
Kim et al. Ameliorating effect of 2′-fucosyllactose and 6′-sialyllactose on lipopolysaccharide-induced intestinal inflammation
EP3471562A1 (en) Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders
JP2020529431A5 (cg-RX-API-DMAC7.html)
RU2018127650A (ru) Ферментированная молочная смесь с неперевариваемыми олигосахаридами